Literature DB >> 33623495

HISTOMORPHOLOGICAL PATTERN OF UROLOGIC MALIGNANCIES IN ILE-IFE, SOUTH-WESTERN NIGERIA.

M C Igbokwe1, T A Badmus1, A A Salako1, A O Komolafe2, R A David3, O Z Omoyiola2, A Laoye3, I A Akinbola3, C I Onyeze3, R N Babalola3.   

Abstract

INTRODUCTION: The last decade witnessed a remarkable rise in the prevalence of several malignant diseases in Nigeria. Whether Urologic malignancies (UM) have followed the same trend remains to be studied. The pattern of UM diagnosed in a Nigerian tertiary hospital is hereby presented. Our aim was to determine the pattern and prevalence of histologically diagnosed UM in Obafemi Awolowo University Teaching Hospitals Complex. Ile-Ife, Nigeria.
MATERIALS AND METHODS: A 10-year retrospective review of all patients diagnosed with UM was carried out between January 2005 and December 2014. Data was obtained from the patients' case files and the Ife-Ijesha Cancer registry. Information obtained included demographic characteristics, site of origin and histology. Data was analysed with Statistical package for Social sciences (SPSS) Version 20.
RESULTS: A total of 4675 malignancies were histologically confirmed during the study period. UM accounted for 420 (8.9%) of total malignancies. Prostate cancer was the commonest UM with 315 (75%) cases. Others include renal tumours 62(14.8%), bladder tumours 29 (6.9%), testicular tumours 13(3.1%) and scrotal tumour 1(0.2%). UM were commoner in males (348, 88.8%) than females (47, 11.2%) and accounted for 13.8% and 2.18% of all tumours in males and females respectively.
CONCLUSION: This study revealed a rising prevalence of UM most especially Prostate and Renal Cancers among other malignancies in Ile-Ife. © Association of Resident Doctors, UCH, Ibadan.

Entities:  

Keywords:  Ile-Ife.; Pattern; Urologic malignancies

Year:  2020        PMID: 33623495      PMCID: PMC7893300     

Source DB:  PubMed          Journal:  Ann Ib Postgrad Med


INTRODUCTION

Urologic malignancies (UM) are encountered worldwide with varying patterns and prevalence[1]. UM are major causes of morbidity and mortality with a significant effect on age-adjusted life years in afflicted individuals[2]. Technological advancement in diagnostic modalities, minimal access surgery and modern drugs have changed the face of diagnosis and treatment of UM[2]. Nigeria, the most populous black nation in the world has witnessed an increasing burden of UM in the past decade especially Prostate cancer (PCa)[3,4]. Reports from tertiary centres in different geo-political zones of Nigeria have shown some epidemiological peculiarities in the pattern of UM with higher reports of bladder cancer in the Northern part of Nigeria[5]. In the oil-rich Southern Nigeria, certain genetic predisposing factors and environmental exposure have been alluded to in the aetio-pathogenesis of some UM[6,7]. From previous studies, UM account for a significant burden of cancer patients in Nigeria. Prostate and bladder cancer have been shown to be the commonest malignancies across Nigeria in papers from South-south and North-western Nigeria respectively[5,8]. There is however paucity of information on the recent pattern of UM in South-western Nigeria. This study aims to analyse the pattern of GUM diagnosed at the Ife-Ijesha cancer registry over a 10-year period.

MATERIALS AND METHODS

A 10-year retrospective review of all patients with histological diagnosis of GUM between January 2005 and December 2014 at Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife was done. Data was obtained from the patients case files and the Ife-Ijesha Cancer registry. Information obtained include demographic characteristics, site of origin and histologic details. The diagnosis was based on the World Health Organization’s classification of varied urological cancers. Data was analysed with Statistical package for Social Sciences (SPSS) Version 20.

RESULTS

UM accounted for 8.9% (420 of 4675) of malignancies diagnosed within the study period. Of all malignancies diagnosed and registered in the cancer registry, there was a marginal male predominance with male cancers numbering 2517 (53.8%) and female cancers 2158 (46.2%). Overall, UM made up 14.82% of male malignancies and 2.18% of female malignancies. UM were commoner in males 373 (88.8%) than females 47 (11.2%) with a male:female ratio of 9 : 1. The mean age of patients with UM were 53.5 years. Mean ages for different urologic tumours are depicted on Table 1.
Table 1:

Summary of genito-urinary malignancies in Ile-Ife (From Ife-Ijesha Cancer Registry).

Tumours Total (% of total Malignancies)% of Adult Urologic MalignanciesMean Age (years)

Prostate Cancer 315 (6.74) 75 69.80
Renal Cancer 62 (1.33) 14.76 41.70
Bladder Cancer 29 (0.62) 6.90 63.60
Testicular Cancer 13 (0.28) 3.10 30.60
Scrotal Cancer 1 (0.022) 0.24 62.00
Total 420 (8.98) 100
The primary organs affected were the Prostate (315;75%), the kidney (62;14.8%), the bladder (29;6.9%), the testis (13;3.1%) and the scrotum (1;0.24%). The peak age for prostate cancer was in the 7th decade of life with histology of Adenocarcinoma accounting for all. Renal Cell Carcinoma was the second commonest malignancy and was seen more commonly in females (37; 59.7%) than males (25; 41.3%) with the clear cell variant making up greater than one third of the patients. Bladder tumours ranked third and were more commonly found in men (19;65.6%) than women (10;34.4%) with transitional cell carcinoma variant making up more than half of the cases. Other histological details are as seen on Table 2. Testicular tumours and a solitary case of scrotal squamous cell carcinoma accounted for the rest. No cases of renal pelvis, ureteral, urethral or penile tumours were managed during the study period.
Table 2:

Histopathological breakdown of GUM in Ile-Ife.

Tumours Histological details Frequency (%)

Prostate Cancer Adenocarcinoma315 (100)
High grade PIN7
Bladder Cancer Transitional Cell Carcinoma16 (55.2)
Squamous Cell Ca6 (20.7)
Adenocarcinoma4 (13.8)
Metastatic Cancers3 (10.3)
Renal CancerRenal Cell Carcinoma37 (59.7)
Clear Cell RCC11 (17.7)
Chromophobe7 (11.3)
Papillary3 (4.8)
Sarcomatoid1 (1.6)
Mixed1 (1.6)
Multi-locular Cystic1 (1.6)
Collecting Duct1 (1.6)
Testicular CancerGCT5 (38.4)
Seminoma4 (30.8)
Paratesticular tumours2 (15.4)
Rhabdomyosarcoma1 (7.7)
Adenomatoid tumour1 (7.7)
Scrotal Cancer Squamous Cell Carcinoma 1 (100)

DISCUSSION

This review shows that over the last decade, UM accounted for 8.4% of all histologically diagnosed malignancies in our immediate community. This suggests that 1 in every 10 cases of cancer is a UM. This was similar to findings in Jos, Korle-Bu and Zambia[9-11]. It was however less prevalent than in studies from Kano and India[2,8]. Compared to the year 2005, the 60% rise in overall prevalence of UM from 2011-2014 are mostly attributable to Prostate and Renal Cancers. This could be attributed to more recent community-based health education and screening programs in Ile-Ife community associated with higher number of apparently healthy patients presenting for routine prostate specific antigen checks, ultrasound scans and prostate biopsies. There has also been a rise in incidental diagnosis of renal tumours during routine ultrasound scans in Ile-Ife in recent times[12]. Dauda and his associates also corroborated a rise in the prevalence of UM in North-eastern Nigeria[13]. Historically, it was believed that PCa was relatively rare among men of African descent[14], our study contrarily buttresses the high prevalence of PCa in our environment accounting for 75% of all UM. There is overwhelming evidence in literature that PCa is the commonest UM[3,8,9,13,15,16]. In Nigeria, PCa has surpassed Hepatocellular carcinoma as the commonest malignancy in men[3]. Adenocarcinoma was the dorminant histological type of PCa in our study which is similar to other local and international reports[1,8]. Findings of renal cell carcinoma (RCC) as the second commonest urological cancer in this studyis contrary to majority of studies from across Nigeria where bladder tumour has since been reported as the second commonest UM[5,8,9,13]. Perhaps the relative rural environment devoid of exposure to industrial carcinogens as well as paucity of schistosoma endemic streams may account for this peculiarity. This study shows that the mean age for RCC was 41.7 years and it was found to be more common among women with Male: Female ratio of 1: 1.5. The lower mean age and increased prevalence among women was a sharp contrast to a previous report from our center where a mean age of 47.5 years and male: female ratio of 13:517. In Nigeria, Tijani and Mbaeri et al in Lagos and Nnewi respectively,also found a higher incidence of RCC in females[18,19]. Reasons for these differences were attributed to the increased number of women with incidentally discovered RCC during routine ultrasound in pregnancy. The clear cell variant was the commonest histological type in this study, this was different from the papillary cell variant which was reported by Ofuru and his assocites reported in Port-Harcourt, Nigeria[5]. Bladder tumours were the third commonest urological malignancy in our study with male:female ratio of 2:1. This ratio was similar to findings by Forae in Benin and Takure et al in Ibadan, both in Nigeria[20,21] however males were observed to have a much higher ratio of 5.6: 1 in Port-Harcourt[5]. Urothelial tumour (transitional cell carcinoma) was the commonest histological type found in our report. This is in keeping with the global trends[2]. Even in the Northern part of Nigeria, there seems to be a change in the trend ofbladder tumours with higher incidence of urothelial tumours compared to Squamous cell Carcinoma as was seen two decades ago due to endemicity of schistosomiasis in these parts[9,22]. We generally believe that the semi-urban setting of our immediate environment with a paucity of chemical industries and schistosoma infested streams may have accounted for a lower prevalence of bladder tumours. Testicular tumours were found to be rare with no change in prevalence over the 10-year period under review and it accounted for 3.1% of all urologic malignancies. This is slightly higher than 0.5-2% which is quoted worldwide as incidence of testicular cancer[8,23,24]. Germ cell tumours (GCT) accounted for 38.4% and were the commonest histologic sub-type in this study. This was similar to findings from previous local and international studies[23,25]. Paratesticular tumours especially rhabdomyosarcoma still appear to be relatively common in our community accounting for about half of the patients. This corroborates the report from Salako et al, in 2010 in our hospital who found paratesticular tumours accounting for 38.5% of testicular tumours with majority being rhabdomyosarcoma[26]. There was solitary case of scrotal squamous cell carcinoma which is a rare disease[27].

CONCLUSION

There is an obvious increase in the prevalence of UM in Ile-Ife, mostly accounted for by Prostate and Renal Cancers. This is possibly attributable to increased health education and awareness among indigenes. Renal cancer seems to have replaced bladder cancer as the second commonest UM in Nigeria. There is need for a larger scale National study in order to identify the true pattern of urologic malignancies in Nigeria.
  19 in total

1.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

2.  Trends in incidence of testicular cancer and prostate cancer in Denmark.

Authors:  H Møller
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

3.  Prostate cancer in Nigerians: facts and nonfacts.

Authors:  D N Osegbe
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

4.  The changing pattern of prostate cancer in Nigerians: current status in the southeastern states.

Authors:  Paul D Ekwere; S N Egbe
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

5.  Pattern of urological malignancy in Zambia. A hospital-based histopathological study.

Authors:  B Elem; P S Patil
Journal:  Br J Urol       Date:  1991-01

6.  Prostate cancer incidence and mortality rates and trends in the United States and Canada.

Authors:  Kathleen McDavid; Judy Lee; John P Fulton; Jon Tonita; Trevor D Thompson
Journal:  Public Health Rep       Date:  2004 Mar-Apr       Impact factor: 2.792

7.  Bladder cancer in Kano--a histopathological review.

Authors:  O Ochicha; S Alhassan; A Z Mohammed; S T Edino; E E Nwokedi
Journal:  West Afr J Med       Date:  2003-09

8.  Malignant renal tumors in adults: a ten-year review in a Nigerian hospital.

Authors:  T A Badmus; A A Salako; F A Arogundade; A A Sanusi; A R K Adesunkanmi; E O Oyebamiji; T I B Bakare; G O Oseni
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-01

9.  Testicular cancer in Nigerians.

Authors:  G A Magoha
Journal:  East Afr Med J       Date:  1995-09

Review 10.  Genitourinary cancers: Summary of Indian data.

Authors:  T B Yuvaraja; Santosh Waigankar; Ganesh Bakshi; Gagan Prakash
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.